Filter
2071
Text search:
medicine
product
Featured
Recommendations
194
New Publications
515
Language
Document type
No document type
1014
Studies & Reports
411
Guidelines
348
Manuals
141
Strategic & Response Plan
75
Fact sheets
37
Training Material
27
Situation Updates
10
Resource Platforms
6
Infographics
2
Countries / Regions
Global
97
India
72
Ethiopia
58
Kenya
54
South Africa
51
Nigeria
48
Uganda
39
Latin America and the Carribbean
36
Ghana
33
Nepal
31
Liberia
30
Tanzania
30
Malawi
30
Sierra Leone
29
Western and Central Europe
28
Bangladesh
27
Zambia
25
Rwanda
25
Myanmar / Burma
24
Namibia
22
Philippines
19
South–East Asia Region
17
Africa
16
Zimbabwe
15
Syria
13
Ukraine
13
Lesotho
13
Germany
11
East and Southern Africa
11
Congo, Democratic Republic of
10
Cambodia
10
Mozambique
10
Asia
10
Indonesia
9
Eswatini/ Swaziland
9
West and Central Africa
9
Eastern Europe
9
Haiti
8
Botswana
8
Middle East and North Africa
8
Guinea
7
Burkina Faso
7
Senegal
7
Cameroon
7
Vietnam
7
Pakistan
6
China
6
USA
5
South Sudan
5
Afghanistan
5
Thailand
5
Brazil
5
Albania
5
Sudan
4
Benin
4
Yemen
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Russia
4
United Kingdom
4
Somalia
3
Lebanon
3
Turkey
3
North Macedonia
3
Paraguay
3
Venezuela
3
Moldova
3
Japan
3
Jordan
2
Malaysia
2
Central African Republic
2
Angola
2
Madagascar
2
Fiji
2
Southern Africa
2
Laos
2
Tajikistan
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
Georgia
2
North America
2
Jamaica
2
Spain
2
Bosnia and Herzegovina
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Chad
1
Gambia
1
Argentina
1
Peru
1
Ecuador
1
Libya
1
Guatemala
1
Sri Lanka
1
Chile
1
Other region
1
Poland
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
757
Clinical Guidelines
181
Public Health
115
Key Resources
83
Women & Child Health
77
Pharmacy & Technologies
55
Capacity Building
26
Toolboxes
HIV
138
AMR
138
COVID-19
137
Pharmacy
131
Mental Health
114
TB
114
NTDs
90
Planetary Health
81
NCDs
43
Caregiver
42
Malaria
42
Ebola & Marburg
41
Rapid Response
34
Global Health Education
34
Disability
33
Health Financing Toolbox
32
Conflict
27
Specific Hazards
18
Refugee
17
2.0 Rapid Response
14
Zika
13
Natural Hazards
12
Cholera
7
Social Ethics
5
Polio
3
This module should always be used together with the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-specialized Health
Settings (WHO, 2010), which outlines relevant general
principles of care and management of a range of other
mental, neurological and substa
...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine
...
First Edition~ This self advocacy toolkit for persons with mental, neurological and substance abuse disorders, developed by Basic Needs and CBM, is the end product of an action research intervention that tracked and documented processes for Self
...
At least half of the world’s population does not have full coverage of essential health services. Health expenses push more than 100 million people into extreme poverty each and every year, forcing them into terrible choices that no one should ever have to make: Buy
...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine
...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional
...
"Explosions can produce unique patterns of injury seldom seen outside combat.
When they do occur, they have the potential to inflict multi-system life-threatening injuries
on many persons simultaneously. The injury patterns following such events are a pr
...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to inves
...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells
...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic
...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
-
...
The Multi-professional Patient Safety Curriculum Guide (2011) was developed to assist in the teaching of patient safety in universities and schools in the fields of dentistry, medicine, midwifery, nursing and pharmacy. It also supports the on-going
...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and di
...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing
...
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-health sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiop
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T
...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go
...
